Cargando…

Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties

BACKGROUND AND PURPOSE: Data on application of fast-track/enhanced recovery protocols in revision hip arthroplasty (R-THA) surgery is scarce. We report length of stay (LOS), risk of LOS > 5 days, and readmission ≤ 90 days after revision hip arthroplasty in centers with a well-established fast-tra...

Descripción completa

Detalles Bibliográficos
Autores principales: LINDBERG-LARSEN, Martin, PETERSEN, Pelle Baggesgaard, CORAP, Yasemin, GROMOV, Kirill, JØRGENSEN, Christoffer Calov, KEHLET, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865005/
https://www.ncbi.nlm.nih.gov/pubmed/35195270
http://dx.doi.org/10.2340/17453674.2022.2196
_version_ 1784655567992651776
author LINDBERG-LARSEN, Martin
PETERSEN, Pelle Baggesgaard
CORAP, Yasemin
GROMOV, Kirill
JØRGENSEN, Christoffer Calov
KEHLET, Henrik
author_facet LINDBERG-LARSEN, Martin
PETERSEN, Pelle Baggesgaard
CORAP, Yasemin
GROMOV, Kirill
JØRGENSEN, Christoffer Calov
KEHLET, Henrik
author_sort LINDBERG-LARSEN, Martin
collection PubMed
description BACKGROUND AND PURPOSE: Data on application of fast-track/enhanced recovery protocols in revision hip arthroplasty (R-THA) surgery is scarce. We report length of stay (LOS), risk of LOS > 5 days, and readmission ≤ 90 days after revision hip arthroplasty in centers with a well-established fast-track protocol in both primary and revision procedures. PATIENTS AND METHODS: This is an observational cohort study from the Centre for Fast-track Hip and Knee Replacement and the Danish Hip Arthroplasty Register. Consecutive elective aseptic major component revision hip arthroplasties from 6 dedicated fast-track centers from 2010 to 2018 were included. RESULTS: 1,345 R-THAs were analyzed, including 23% total revisions, 52% acetabular component revisions, and 25% femoral component revisions. Mean age was 70 years (SD 12) and 61% were female. Median LOS was 3 days (interquartile range [IQR] 2–6), decreasing from median 6 (IQR 3–10) days in 2010 to 2 (IQR 1–4) days in 2018. The 90-day readmission rate was 20%, but showed a fluctuating and increasing trend from 13% in 2010 to 28% in 2018. Risk factors for LOS > 5 days and readmission were use of walking aid, preoperative hemoglobin ≤ 13 g/dL, pharmacological treated psychiatric disorder, age ≥ 80 years, age 70–79 years (only LOS > 5 days), cardiac disease (only LOS > 5 days), pulmonary disease (only readmission), BMI ≥ 35 (only LOS > 5 days) and ≥ 1 previous revision (only LOS > 5 days). INTERPRETATION: LOS decreased to median 2 days at the end of the study period, but the 90 days readmission risk remained high (> 20%). Several risk factors for postoperative complications were identified, suggesting that at-risk patients should be treated using an extended fast-track/enhanced recovery protocol focusing on preoperative optimization and postoperative monitoring as well as surgical techniques to reduce hip dislocations.
format Online
Article
Text
id pubmed-8865005
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation
record_format MEDLINE/PubMed
spelling pubmed-88650052022-03-04 Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties LINDBERG-LARSEN, Martin PETERSEN, Pelle Baggesgaard CORAP, Yasemin GROMOV, Kirill JØRGENSEN, Christoffer Calov KEHLET, Henrik Acta Orthop Article BACKGROUND AND PURPOSE: Data on application of fast-track/enhanced recovery protocols in revision hip arthroplasty (R-THA) surgery is scarce. We report length of stay (LOS), risk of LOS > 5 days, and readmission ≤ 90 days after revision hip arthroplasty in centers with a well-established fast-track protocol in both primary and revision procedures. PATIENTS AND METHODS: This is an observational cohort study from the Centre for Fast-track Hip and Knee Replacement and the Danish Hip Arthroplasty Register. Consecutive elective aseptic major component revision hip arthroplasties from 6 dedicated fast-track centers from 2010 to 2018 were included. RESULTS: 1,345 R-THAs were analyzed, including 23% total revisions, 52% acetabular component revisions, and 25% femoral component revisions. Mean age was 70 years (SD 12) and 61% were female. Median LOS was 3 days (interquartile range [IQR] 2–6), decreasing from median 6 (IQR 3–10) days in 2010 to 2 (IQR 1–4) days in 2018. The 90-day readmission rate was 20%, but showed a fluctuating and increasing trend from 13% in 2010 to 28% in 2018. Risk factors for LOS > 5 days and readmission were use of walking aid, preoperative hemoglobin ≤ 13 g/dL, pharmacological treated psychiatric disorder, age ≥ 80 years, age 70–79 years (only LOS > 5 days), cardiac disease (only LOS > 5 days), pulmonary disease (only readmission), BMI ≥ 35 (only LOS > 5 days) and ≥ 1 previous revision (only LOS > 5 days). INTERPRETATION: LOS decreased to median 2 days at the end of the study period, but the 90 days readmission risk remained high (> 20%). Several risk factors for postoperative complications were identified, suggesting that at-risk patients should be treated using an extended fast-track/enhanced recovery protocol focusing on preoperative optimization and postoperative monitoring as well as surgical techniques to reduce hip dislocations. Medical Journals Sweden, on behalf of the Nordic Orthopedic Federation 2022-02-23 /pmc/articles/PMC8865005/ /pubmed/35195270 http://dx.doi.org/10.2340/17453674.2022.2196 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
spellingShingle Article
LINDBERG-LARSEN, Martin
PETERSEN, Pelle Baggesgaard
CORAP, Yasemin
GROMOV, Kirill
JØRGENSEN, Christoffer Calov
KEHLET, Henrik
Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties
title Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties
title_full Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties
title_fullStr Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties
title_full_unstemmed Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties
title_short Fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties
title_sort fast-track revision hip arthroplasty: a multicenter cohort study on 1,345 elective aseptic major component revision hip arthroplasties
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865005/
https://www.ncbi.nlm.nih.gov/pubmed/35195270
http://dx.doi.org/10.2340/17453674.2022.2196
work_keys_str_mv AT lindberglarsenmartin fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties
AT petersenpellebaggesgaard fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties
AT corapyasemin fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties
AT gromovkirill fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties
AT jørgensenchristoffercalov fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties
AT kehlethenrik fasttrackrevisionhiparthroplastyamulticentercohortstudyon1345electiveasepticmajorcomponentrevisionhiparthroplasties